Zeit | Aktuelle Nachrichten | Rating | Leser | ||
---|---|---|---|---|---|
02.10. | Gresham House Energy Storage Fund - Rising revenues and big plans for the future | 145 | Gresham House Energy Storage Fund (GRID) invests in utility-scale battery energy storage systems (BESS) in Great Britain. The sector had a tough start to the year, due to a deterioration in revenue... ► Artikel lesen | ||
02.10. | International Public Partnerships - FHSP partial realisation with £30m exit proceeds | 215 | International Public Partnerships (INPP) has announced the partial disposal of its Public-Private Partnerships (P3) investment providing family housing for US service personnel. The £30m proceeds take... ► Artikel lesen | ||
02.10. | Oryzon Genomics - FDA aligns on Phase III BPD plans | 264 | Oryzon Genomics has confirmed the FDA's alignment with its proposed Phase III programme for vafidemstat in borderline personality disorder (BPD). Notably, the FDA acknowledged agitation and aggression... ► Artikel lesen | ||
02.10. | Topps Tiles - Slight sequential improvement in Q424 | 198 | Topps Tiles (TPT) finished FY24 well on a relative basis by outperforming the still weak domestic repair, maintenance and improvement market. Its Q424 trading update indicates reassuring 'stable' trends... ► Artikel lesen | ||
01.10. | Greggs - Good Q324 on strong comparative | 280 | Greggs demonstrated continued strong sales growth in Q324, against a challenging Q323 comparative. The company continues to benefit from its multipronged growth strategy of increasing space, extended... ► Artikel lesen | ||
01.10. | SDCL Energy Efficiency Income Trust - Portfolio growth ahead of budget | 234 | SDCL Energy Efficiency Income Trust's (SEEIT's) interim update (for the six months to 30 September 2024) has highlighted that its operational assets, on a consolidated basis, are performing in line... ► Artikel lesen | ||
01.10. | IRLAB Therapeutics - Pirepemat Phase IIb trial completes enrolment | 196 | IRLAB Therapeutics has announced the completion of patient enrolment for the Phase IIb trial (React PD) assessing pirepemat's ability to improve balance and reduce falls in Parkinson's disease patients... ► Artikel lesen | ||
01.10. | Regional REIT - A clear strategy to realise value | 257 | Regional REIT's (RGL's) H124 performance had been well flagged during its equity raising and provided no surprises. With the £110.5m equity raise completed and the (£50m) retail bond repaid, investor... ► Artikel lesen | ||
30.09. | AFT Pharmaceuticals - Maxigesic IV reaches the Chinese shores | 167 | AFT Pharmaceuticals has taken another major step in extending its international footprint, with the signing of an exclusive license agreement for Maxigesic IV in China, the second-largest pharma market... ► Artikel lesen | ||
30.09. | Nano Dimension - Scaling up | 356 | Nano Dimension has agreed to acquire Markforged, a specialist in additive manufacturing (AM) for metal and advanced composites, for cash of $115m. The deal requires regulatory and Markforged shareholder... ► Artikel lesen | ||
27.09. | Pan African Resources - Analysing H224 and looking forward to FY25 | 280 | Pan African Resources' (PAF's) FY24 results, announced on 11 September, were within 1% of our prior forecasts for both EPS (4.14c cf 4.17c) and headline EPS (HEPS; 4.15c cf 4.17c). However, if the contract... ► Artikel lesen | ||
26.09. | Substrate AI - AI venture builder | 190 | Substrate AI buys, builds and scales ventures with proprietary artificial intelligence (AI) to transform companies across a range of sectors into AI driven businesses. Its core technology, Serenity... ► Artikel lesen | ||
26.09. | Greencoat Renewables - Efficient capital allocation and increasing demand | 307 | Greencoat Renewables' (GRP's) large and diversified pan-European portfolio of renewable energy assets generated net cash of €113.6m in H124 (H123: €125.5m). This equated to gross dividend cover of 3x... ► Artikel lesen | ||
26.09. | Henderson International Income Trust - Buying into the rapid spread of technology | 233 | Henderson International Income Trust (HINT) seeks out companies with potential for growth from exposure to structural themes that is not priced into their valuations. The trust's manager, Ben Lofthouse... ► Artikel lesen | ||
25.09. | Impact Healthcare REIT - Successful turnaround | 183 | Impact Healthcare REIT has completed the transfer of four homes located in Scotland to a new tenant. As a result, all of the seven homes that have been operating on an intermediate basis (as part of... ► Artikel lesen | ||
25.09. | abrdn UK Smaller Companies Growth Trust - Solid relative performance recovery continues | 190 | abrdn UK Smaller Companies Growth Trust's (AUSC's) relative performance continues to improve as managers Abby Glennie and Amanda Yeaman build on the solid outperformance of the trust versus the reference... ► Artikel lesen | ||
25.09. | Sylvania Platinum - Earnings upside with chrome JV kicker in Q425 | 432 | Sylvania reported FY24 EPS of 2.7c against our expectation of 5.8c and down 85% on the prior year due to mainly a 35% lower PGM 4E basket price. In addition, the company suffered the effects of much... ► Artikel lesen | ||
25.09. | Accsys Technologies - Tricoya project to be discontinued | 429 | Accsys will discontinue the Tricoya project in Hull, England, as it has not found a financial or strategic partner to finalise the construction of the plant. The project started in 2017 and was put... ► Artikel lesen | ||
25.09. | Esker - Proposed bid for the company confirmed | 320 | Alongside its H124 results, Esker confirmed that Bridgepoint, in association with General Atlantic and management shareholders, is proposing a cash public tender offer for the company at €262 per share.... ► Artikel lesen | ||
24.09. | Basilea Pharmaceutica - BARDA backs Basilea's anti-infectives programme | 291 | Basilea has bagged a multi-year agreement with the Biomedical Advanced Research and Development Authority (BARDA), potentially worth US$268m, to advance its anti-infectives franchise. The Other Transaction... ► Artikel lesen | ||
24.09. | International Public Partnerships - Attractive, lower-risk returns | 211 | International Public Partnerships' (INPP's) portfolio continues to deliver consistent and predictable returns for investors, while providing environmental and social benefits for the individuals and... ► Artikel lesen | ||
24.09. | Boku - H124 revenue growth supports FY24 outlook | 297 | Boku reported 24% y-o-y revenue growth in H124, with both digital wallet/account-to-account (A2A) payments and direct carrier billing (DCB) payments growing at double-digit rates. Adjusted EBITDA grew... ► Artikel lesen | ||
24.09. | Metals One - First by name, first by nature | 202 | Metals One is a junior metals explorer with assets in Finland and Norway. After listing on the London Stock Exchange last year, it has moved quickly to double the resource at its Black-Schist project... ► Artikel lesen | ||
23.09. | Oryzon Genomics - Final PORTICO data reaffirms potential in BPD | 247 | Oryzon has presented the results of the final analysis from the Phase IIb PORTICO trial, which evaluated the efficacy and safety of vafidemstat in borderline personality disorder (BPD). While top-line... ► Artikel lesen | ||
23.09. | S&U - Timing is everything | 186 | Interim results, for the six months to 31 July (H125), will be published on 8 October. Ahead of that, S&U has alerted the market that based on the H1 performance, full year PBT is unlikely to meet the... ► Artikel lesen |